Reliability and Reproducibility of Absolute Myocardial Blood Flow: Does It Depend on the PET/CT Technology, the

K Lance Gould1,2, Linh Bui3, Danai Kitkungvan3

  • 1Weatherhead PET Center For Preventing and Reversing Atherosclerosis, Division of Cardiology, Department of Medicine, McGovern Medial Medical School, University of Texas, and Memorial Hermann Hospital, Houston, TX, USA. k.lance.gould@uth.tmc.edu.

Insights

Revascularization may reduce mortality in coronary artery disease (CAD) when guided by comprehensive coronary flow capacity (CFC) imaging. Current methods fail to identify patients who benefit, leading to suboptimal outcomes.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Interventional Cardiology

Background:

  • The COURAGE and ISCHEMIA trials indicated no mortality benefit from revascularization versus medical management in coronary artery disease (CAD).
  • This lack of benefit may stem from inadequate patient selection due to non-quantitative cardiac imaging methods.
  • Current imaging focuses on isolated parameters, failing to capture the integrated severity of CAD.

Purpose of the Study:

  • To investigate if comprehensive, quantitative myocardial perfusion imaging can identify CAD patients who benefit from revascularization.
  • To explore the role of coronary flow capacity (CFC) in guiding revascularization decisions for improved mortality outcomes.
  • To address methodologic questions regarding optimal patient selection for revascularization in non-acute CAD.

Main Methods:

  • Utilizing comprehensive, integrated myocardial perfusion quantification through regional pixel distribution of coronary flow capacity (CFC).
  • Moving beyond single-metric assessments like stenosis, FFR, or global CFR.
  • Focusing on the regional pixel distribution of perfusion metrics for individual patient assessment.

Main Results:

  • Comprehensive, integrated CFC is proposed as the objective measure of CAD severity that predicts mortality benefit from revascularization.
  • Current revascularization strategies lack benefit due to narrow, non-quantitative imaging assessments.
  • Artery-specific interventions guided by integrated CFC can reduce mortality in non-acute CAD.

Conclusions:

  • Revascularization benefit in CAD is contingent on objective, comprehensive assessment of myocardial perfusion via CFC.
  • Improved patient selection using quantitative perfusion imaging is crucial for realizing revascularization benefits.
  • Further research is needed to address methodologic challenges in implementing CFC for guiding revascularization.
Abstract